BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 35078530)

  • 21. Do randomized controlled nursing trials have a pragmatic or explanatory attitude? Findings from the Pragmatic-Explanatory Continuum Indicator Summary (PRECIS) tool exercise.
    Palese A; Bevilacqua MG; Dante A;
    J Nurs Res; 2014 Sep; 22(3):216-20. PubMed ID: 25111115
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structured, intensive education maximising engagement, motivation and long-term change for children and young people with diabetes: a cluster randomised controlled trial with integral process and economic evaluation - the CASCADE study.
    Christie D; Thompson R; Sawtell M; Allen E; Cairns J; Smith F; Jamieson E; Hargreaves K; Ingold A; Brooks L; Wiggins M; Oliver S; Jones R; Elbourne D; Santos A; Wong IC; O'Neill S; Strange V; Hindmarsh P; Annan F; Viner R
    Health Technol Assess; 2014 Mar; 18(20):1-202. PubMed ID: 24690402
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The value of the pragmatic-explanatory continuum indicator summary wheel in an ongoing study: the bullous pemphigoid steroids and tetracyclines study.
    Bratton DJ; Nunn AJ; Wojnarowska F; Kirtschig G; Sandell A; Williams HC
    Trials; 2012 Apr; 13():50. PubMed ID: 22540678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The We Can Quit2 Smoking Cessation Trial: Knowledge Exchange and Dissemination Following a Community-Based Participatory Research Approach.
    Castello S; Darker C; Vance J; Dougall N; Bauld L; Hayes CB
    Int J Environ Res Public Health; 2022 Feb; 19(4):. PubMed ID: 35206521
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The PRECIS-2 tool: designing trials that are fit for purpose].
    Hu GP; Zhan SY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Feb; 39(2):222-226. PubMed ID: 29495210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improving the relevance of randomised trials to primary care: a qualitative study investigating views towards pragmatic trials and the PRECIS-2 tool.
    Forbes G; Loudon K; Clinch M; Taylor SJC; Treweek S; Eldridge S
    Trials; 2019 Dec; 20(1):711. PubMed ID: 31829266
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Articles provided insufficient information to conduct an appropriate retrospective assessment of the pragmatic/explanatory features of medicine trials with the PRECIS-2 tool.
    Dal-Ré R
    Eur J Clin Pharmacol; 2020 Aug; 76(8):1093-1102. PubMed ID: 32447436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carer administration of as-needed subcutaneous medication for breakthrough symptoms in people dying at home: the CARiAD feasibility RCT.
    Poolman M; Roberts J; Wright S; Hendry A; Goulden N; Holmes EA; Byrne A; Perkins P; Hoare Z; Nelson A; Hiscock J; Hughes D; O'Connor J; Foster B; Reymond L; Healy S; Lewis P; Wee B; Johnstone R; Roberts R; Parkinson A; Roberts S; Wilkinson C
    Health Technol Assess; 2020 May; 24(25):1-150. PubMed ID: 32484432
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An intervention to improve the quality of life in children of parents with serious mental illness: the Young SMILES feasibility RCT.
    Abel KM; Bee P; Gega L; Gellatly J; Kolade A; Hunter D; Callender C; Carter LA; Meacock R; Bower P; Stanley N; Calam R; Wolpert M; Stewart P; Emsley R; Holt K; Linklater H; Douglas S; Stokes-Crossley B; Green J
    Health Technol Assess; 2020 Nov; 24(59):1-136. PubMed ID: 33196410
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A feasibility randomised controlled trial of a motivational interviewing-based intervention for weight loss maintenance in adults.
    Simpson SA; McNamara R; Shaw C; Kelson M; Moriarty Y; Randell E; Cohen D; Alam MF; Copeland L; Duncan D; Espinasse A; Gillespie D; Hill A; Owen-Jones E; Tapper K; Townson J; Williams S; Hood K
    Health Technol Assess; 2015 Jul; 19(50):v-vi, xix-xxv, 1-378. PubMed ID: 26168409
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preoperative behavioural intervention to reduce drinking before elective orthopaedic surgery: the PRE-OP BIRDS feasibility RCT.
    Snowden C; Lynch E; Avery L; Haighton C; Howel D; Mamasoula V; Gilvarry E; McColl E; Prentis J; Gerrand C; Steel A; Goudie N; Howe N; Kaner E
    Health Technol Assess; 2020 Mar; 24(12):1-176. PubMed ID: 32131964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Smoking cessation programmes for women living in disadvantaged communities, "We Can Quit 2": A systematic review protocol.
    Burke E; Dobbie F; Dougall N; Adebolu Oluwaseun M; Mockler D; Vance J; O'Connell N; Darker C; Bauld L; Hayes C
    HRB Open Res; 2019; 2():10. PubMed ID: 32104776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An intervention to support stroke survivors and their carers in the longer term (LoTS2Care): study protocol for a cluster randomised controlled feasibility trial.
    Forster A; Hartley S; Barnard L; Ozer S; Hardicre N; Crocker T; Fletcher M; Moreau L; Atkinson R; Hulme C; Holloway I; Schmitt L; House A; Hewison J; Richardson G; Farrin A;
    Trials; 2018 Jun; 19(1):317. PubMed ID: 29891011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrative Oncology Trials in the Real World: Assessing the Pragmatism of an Ongoing Integrative Oncology Trial of Mindfulness and T'ai Chi/Qigong.
    Carlson LE; Oberoi DV; Qureshi M; Subnis U
    J Altern Complement Med; 2018; 24(9-10):926-932. PubMed ID: 30247962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of explanatory and pragmatic design choices in a cluster-randomized hypertension trial: effects on enrollment, participant characteristics, and adherence.
    Margolis KL; Crain AL; Green BB; O'Connor PJ; Solberg LI; Beran M; Bergdall AR; Pawloski PA; Ziegenfuss JY; JaKa MM; Appana D; Sharma R; Kodet AJ; Trower NK; Rehrauer DJ; McKinney Z; Norton CK; Haugen P; Anderson JP; Crabtree BF; Norman SK; Sperl-Hillen JM
    Trials; 2022 Aug; 23(1):673. PubMed ID: 35978336
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers.
    Thorpe KE; Zwarenstein M; Oxman AD; Treweek S; Furberg CD; Altman DG; Tunis S; Bergel E; Harvey I; Magid DJ; Chalkidou K
    J Clin Epidemiol; 2009 May; 62(5):464-75. PubMed ID: 19348971
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.